Table 3:
Proportion of individuals having each combination of either two or three pathologies in the entire cohort of 161 CN subjects
| Pathology 1 | Pathology 2 | Pathology 3 | |||
|---|---|---|---|---|---|
| Tau | α-Synuclein | TDP-43 | Vascular | ||
| Combinations of any two pathologies | |||||
| β-Amyloid | 40% | 12% | 14% | 28% | NA |
| Tau | 11% | 11% | 20% | NA | |
| α-Synuclein | 3% | 5% | NA | ||
| TDP-43 | 8% | NA | |||
| Combinations of any three pathologies | |||||
| β-Amyloid | 10% | NA | α-Synuclein | ||
| β-Amyloid | 8% | 2% | NA | TDP-43 | |
| β-Amyloid | 16% | 4% | 6% | NA | Vascular |
| Tau | 2% | NA | TDP-43 | ||
| Tau | 3% | 4% | NA | Vascular | |
| α-Synuclein | 1% | NA | Vascular | ||